A fatty diet left lasting senescence-like scars in the liver's regenerative cells — in rats

Edited by Samael A. Tejada, Founder & Editor-in-Chief

The unsettling idea in this study is cellular memory. The regenerative cells did not recover simply because the fatty environment was taken away — they carried the diet's signature through weeks of clean culture, in their senescence markers, their inflammatory responses and their mitochondria. And the rescue experiment draws a sharp line: a mitochondria-targeted compound helped the cells rebuild, while a general antioxidant that merely lowered a ROS readout did not.

What did the fatty diet do to the liver itself?

High-fat-fed rats gained more weight from week four and ate more calories from week one, with more white adipose tissue, higher total and non-HDL cholesterol, marked liver fat accumulation and more lipid peroxidation. Their livers carried higher levels of the inflammatory cytokines IL-1beta, IL-6 and TNF-alpha, and the senescence panel shifted in the aging direction across the board: more beta-galactosidase-positive area, more p16-, p21- and gamma-H2AX-positive cells, and less Lamin B1. Two weeks after the final injection in the regeneration challenge, proliferating Ki67-positive cells were significantly fewer — and a greater share of those still dividing also carried p16 or gamma-H2AX, as if regeneration were proceeding under a cloud of damage.

How do we know the damage was remembered, not just ongoing?

The organoid experiment is the test. Organoid-forming cells were taken out of the animals and grown in identical clean conditions, passaged repeatedly. If the defects were only a response to the obese bloodstream, they should have washed out. They did not: high-fat-derived organoids were smaller, lost formation efficiency from the third passage, and showed markedly diminished self-renewal over 13 passages in Kaplan-Meier analysis. Senescence differences persisted through passages 2 and 3, RNA sequencing found 29 upregulated and 71 downregulated genes (including the senescence-associated Gpnmb, also raised in the animals' livers), and the gene programs for lipid metabolism, inflammation, oxidative stress and mitochondrial function were all activated. Challenged with fatty acids, the high-fat-derived organoids mounted a stronger inflammatory response and accumulated more lipid, with higher expression of the uptake genes Cd36 and Fatp1.

What did MitoQ rescue — and what did it not?

On the mitochondrial side, the high-fat-derived organoids consumed less oxygen, held less mitochondrial DNA, expressed less Mto1, Mrps24 and Tfam, and showed depolarized membranes on JC-1 staining. MitoQ — an antioxidant engineered to accumulate inside mitochondria — significantly reduced reactive oxygen species, lowered TNF-alpha and MCP-1 secretion, restored oxygen consumption to levels comparable to control-derived organoids, and significantly improved organoid formation at passage 3, though recovery remained incomplete. N-acetylcysteine reduced the measured ROS signal without significantly improving formation, and the NF-kB inhibitor BAY 11-7082 likewise failed to rescue it — evidence the authors read as showing that regenerative recovery tracks mitochondrial function, not just a lower oxidant number. The authors themselves use 'senescence-like' deliberately: irreversible arrest at the single-cell level was not established, the cell origin of the organoid-forming population was not determined, and persistence was shown at population level in male rats on one diet.

Where the evidence stands

• Established: Chronic high-fat feeding causes liver fat accumulation, oxidative stress, inflammation and impaired liver regeneration in animal models; cellular senescence markers such as p16, p21 and gamma-H2AX rise with metabolic stress and aging.
• Preliminary: In male rats and liver organoids derived from them (Aging Cell, 2026; e70769), high-fat feeding durably reprogrammed the regenerative compartment toward a senescence-like state with mitochondrial dysfunction (lower respiration, mtDNA and membrane potential) that persisted in culture, and the mitochondria-targeted antioxidant MitoQ partly restored respiration and organoid formation in vitro.
• Absent: Human evidence of any kind, female animals, any demonstration that the effect occurs in people, and any evidence that MitoQ improves liver repair in a living animal or survives treatment withdrawal.